Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Mutation Research|May 1, 2013
Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese womenNathalie K Zgheib, Ashraf A Shamseddine, Eddy Geryess, et al.
World Journal of Oncology|August 28, 2020
Current Status and Future Perspectives of Immunotherapy in Middle-Income Countries: A Single-Center Early ExperienceImad Bou Akl, Juliett Berro, Arafat Tfayli, et al.
Frontiers in Nutrition|March 27, 2023
Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort studySally Temraz, Jana Jabbour, Farah Nassar, et al.
World Journal of Surgical Oncology|April 27, 2012
Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle EastElias Elias, Deborah Mukherji, Walid Faraj, et al.
Current Treatment Options in Oncology|May 24, 2025
Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management StrategiesLaudy Chehade, Noura Abbas, Kristel Dagher, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical CenterFady B Geara, Elie Nasr, Susan L Tucker, et al.
Breast Cancer (Dove Medical Press)|July 4, 2017
Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohortAlissar El Chediak, Raafat S Alameddine, Ayman Hakim, et al.
The Oncologist|July 1, 2017
Appendiceal Mucinous Neoplasms: Diagnosis and ManagementWalid L Shaib, Rita Assi, Ali Shamseddine, et al.
Molecular and Clinical Oncology|December 2, 2015
A multicenter, phase II study of the RAF-kinase inhibitor sorafenib in patients with advanced renal cell carcinomaHussein Khaled, Hamdy Abdel Azim, Emad Barsoum, et al.
American Journal of Clinical Oncology|August 3, 2005
A clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC)Ali Shamseddine, Mohammed Khalifeh, Aref Chehal, et al.
Pageof 18